Received Mar 23, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 93H32 | — |
Kinrix is licensed for use 4 to 6 year olds, when administered to a child younger than 4 years as DTaP and IPV doses 1, 2, or 3 does count as valid if all minimum intervals are met. Appropriate intervals were met. Re-administration of DTaP and IPV are not required. Patient had no adverse outcome.